Evidence-Based GI: An ACG Publication and Podcast

Podcast készítő American College of Gastroenterology - Szerdák

138 Epizód

Ozanimod, a Selective Selective Sphingosine-1-Phosphatase Receptor Modulator, for Moderate-Severe Ulcerative Colitis: Re-Thinking the Top-Down Treatment Algorithm for UC
Közzétéve: 2022. 12. 13.
Continuing Anti-TNF Agents past 24 Weeks of Pregnancy Associated with Fewer IBD Relapses with No Increase in Adverse Fetal Outcomes
Közzétéve: 2022. 12. 13.
NSAID Use and the Risk of IBD Exacerbations: Fact or Fiction
Közzétéve: 2022. 12. 13.
RBX2660, a Donor Stool Product for Fecal Microbiota Transplant, Decreases Recurrent Clostridioides difficile Infection: The First FDA-Approved Live Biotherapeutic Product
Közzétéve: 2022. 12. 13.
ICYMI: Surgery is Superior to Medical Therapy for PPI-Refractory Heartburn in the “Right” Patients
Közzétéve: 2022. 11. 11.
Vonoprazan, a Potassium-Channel Acid Blocker, is Superior to Lansoprazole for Managing Erosive Esophagitis
Közzétéve: 2022. 11. 11.
Reinvestigating the Lack of Association Between Proton Pump Inhibitor Use and Mortality by Accounting for Reverse Causation
Közzétéve: 2022. 11. 11.
Upadacitinib, a Selective JAK1 Inhibitor, for Moderate-Severe Ulcerative Colitis: Adjusting the Top-Down Treatment Algorithm for UC
Közzétéve: 2022. 10. 18.
Acute pancreatitis: Need IV fluid resuscitation but avoid a WATERFALL!
Közzétéve: 2022. 10. 18.
High Adenoma Detection Rate Decreases Post-Colonoscopy CRC in FIT-Based Screening Program: Quality Matters!
Közzétéve: 2022. 10. 18.
Colonoscopy Reduces CRC Incidence and CRC-Related Mortality…. If You Get It!
Közzétéve: 2022. 10. 18.
ICYMI-Pantoprazole Prophylaxis Does Not Reduce 90-day Mortality and Clinically Significant Adverse Events in ICU Patients
Közzétéve: 2022. 09. 21.
Achieve IBD Remission Before Pregnancy: PIANO Registry Data Shows Adverse Perinatal Outcomes For Infants Associated with IBD Flares and Steroid Use; and Continue Thiopurines and Anti-TNF Agents If You
Közzétéve: 2022. 09. 21.
Time to Increase Adenoma Detection Rate Benchmarks for Screening Colonoscopies
Közzétéve: 2022. 09. 21.
ADR Isn’t the Only Game in Town: Proximal Serrated Lesion Detection Rates Predicts Interval Cancer Risk
Közzétéve: 2022. 08. 11.
Tiny Polyps-It’s OK to Remove Polyps equal or less than 3mm with Large Biopsy Forceps
Közzétéve: 2022. 08. 11.
Prophylactic Rifaximin Decreases Post-TIPS Hepatic Encephalopathy
Közzétéve: 2022. 08. 11.
SER-109, an Oral Microbiome Therapy, Decreases Recurrent Clostridiodes difficile Infection
Közzétéve: 2022. 06. 16.
When Is Routine Prophylactic Clipping Indicated Post-Polypectomy?
Közzétéve: 2022. 06. 09.
Tenapanor (IBSRELA) for Treatment of IBS-C: Effective over 26 Weeks
Közzétéve: 2022. 06. 02.

6 / 7

A new monthly publication from the American College of Gastroenterology, Evidence-Based GI (EBGI) uses evidence-based methods to create abstracts and explain study results of new and important articles in the field of gastroenterology and hepatology. Listen as editors of EBGI discuss the articles they review and how the recommendations can be applied to your practice.

Visit the podcast's native language site

138 Epizód

Ozanimod, a Selective Selective Sphingosine-1-Phosphatase Receptor Modulator, for Moderate-Severe Ulcerative Colitis: Re-Thinking the Top-Down Treatment Algorithm for UC

Continuing Anti-TNF Agents past 24 Weeks of Pregnancy Associated with Fewer IBD Relapses with No Increase in Adverse Fetal Outcomes

NSAID Use and the Risk of IBD Exacerbations: Fact or Fiction

RBX2660, a Donor Stool Product for Fecal Microbiota Transplant, Decreases Recurrent Clostridioides difficile Infection: The First FDA-Approved Live Biotherapeutic Product

ICYMI: Surgery is Superior to Medical Therapy for PPI-Refractory Heartburn in the “Right” Patients

Vonoprazan, a Potassium-Channel Acid Blocker, is Superior to Lansoprazole for Managing Erosive Esophagitis

Reinvestigating the Lack of Association Between Proton Pump Inhibitor Use and Mortality by Accounting for Reverse Causation

Upadacitinib, a Selective JAK1 Inhibitor, for Moderate-Severe Ulcerative Colitis: Adjusting the Top-Down Treatment Algorithm for UC

Acute pancreatitis: Need IV fluid resuscitation but avoid a WATERFALL!

High Adenoma Detection Rate Decreases Post-Colonoscopy CRC in FIT-Based Screening Program: Quality Matters!

Colonoscopy Reduces CRC Incidence and CRC-Related Mortality…. If You Get It!

ICYMI-Pantoprazole Prophylaxis Does Not Reduce 90-day Mortality and Clinically Significant Adverse Events in ICU Patients

Achieve IBD Remission Before Pregnancy: PIANO Registry Data Shows Adverse Perinatal Outcomes For Infants Associated with IBD Flares and Steroid Use; and Continue Thiopurines and Anti-TNF Agents If You

Time to Increase Adenoma Detection Rate Benchmarks for Screening Colonoscopies

ADR Isn’t the Only Game in Town: Proximal Serrated Lesion Detection Rates Predicts Interval Cancer Risk

Tiny Polyps-It’s OK to Remove Polyps equal or less than 3mm with Large Biopsy Forceps

Prophylactic Rifaximin Decreases Post-TIPS Hepatic Encephalopathy

SER-109, an Oral Microbiome Therapy, Decreases Recurrent Clostridiodes difficile Infection

When Is Routine Prophylactic Clipping Indicated Post-Polypectomy?

Tenapanor (IBSRELA) for Treatment of IBS-C: Effective over 26 Weeks